Literature DB >> 17559865

Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.

J M Minke1, C Edlund Toulemonde, S Dinic, V Cozette, A Cullinane, J C Audonnet.   

Abstract

A classical limitation of early life immunization is the interference by maternally derived antibodies, which are known to inhibit the immune response to modified-live and killed vaccines. Several studies have convincingly shown that even minute amounts of maternally derived antibodies against equine influenza can strongly interfere with successful vaccination of foals born to immune mares. In this study we evaluated the response of foals born to vaccinated mares to immunization with a canarypox-vectored recombinant vaccine against equine influenza virus H3N8. The recombinant vaccine was able to efficiently prime foals in the presence of maternally derived immunity against influenza as was evidenced by a clear anamnestic antibody response when a secondary vaccination with the same vaccine was performed. The canarypox-vectored recombinant influenza vaccine therefore offers a unique opportunity to overcome the limitations of early life vaccination in the face of maternally derived immunity in foals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559865     DOI: 10.1016/j.jcpa.2007.04.016

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  9 in total

Review 1.  Equine Influenza Virus and Vaccines.

Authors:  Fatai S Oladunni; Saheed Oluwasina Oseni; Luis Martinez-Sobrido; Thomas M Chambers
Journal:  Viruses       Date:  2021-08-20       Impact factor: 5.818

2.  Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza.

Authors:  Cristina Rosas; Gerlinde R Van de Walle; Stephan M Metzger; Karin Hoelzer; Edward J Dubovi; Sung G Kim; Colin R Parrish; Nikolaus Osterrieder
Journal:  Vaccine       Date:  2008-03-31       Impact factor: 3.641

Review 3.  Influenza virus vaccine for neglected hosts: horses and dogs.

Authors:  Woonsung Na; Minjoo Yeom; Huijoon Yuk; Hyoungjoon Moon; Bokyu Kang; Daesub Song
Journal:  Clin Exp Vaccine Res       Date:  2016-07-29

4.  A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus.

Authors:  Sarah Gildea; Sean Arkins; Ann Cullinane
Journal:  Influenza Other Respir Viruses       Date:  2010-11       Impact factor: 4.380

5.  Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.

Authors:  Rebecca L Tallmadge; Steven C Miller; Stephen A Parry; Maria Julia B Felippe
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

Review 6.  A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Authors:  Romain Paillot
Journal:  Vaccines (Basel)       Date:  2014-11-14

Review 7.  The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary.

Authors:  Romain Paillot; Charles M El-Hage
Journal:  Pathogens       Date:  2016-06-10

Review 8.  Viral vector-based influenza vaccines.

Authors:  Rory D de Vries; Guus F Rimmelzwaan
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

Review 9.  Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Authors:  Alejandro Brun; Emmanuel Albina; Tom Barret; David A G Chapman; Markus Czub; Linda K Dixon; Günther M Keil; Bernard Klonjkowski; Marie-Frédérique Le Potier; Geneviève Libeau; Javier Ortego; Jennifer Richardson; Haru-H Takamatsu
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.